|
T9034 |
MK2-IN-3
|
MK2 Inhibitor III |
MAPK
|
|
MK2-IN-3 (MK2 Inhibitor III) is a potent, cell-permeable inhibitor of mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP-K2 or MK-2) and can be used for the treatment of rheumatoid arthritis |
|
T4442 |
MK2-IN-1 hydrochloride
|
MK2 Inhibitor,MK 25 |
MAPK
|
|
MK2-IN-1 hydrochloride (MK 25) is a highly selective, non-ATP competitive inhibitor of p38/mitogen-activated protein kinase-activated protein kinase 2 (MAPKAPK2 or MK2, IC50: 0.11 μM) [1]. |
|
T12058 |
MK2-IN-3 hydrate
|
MK-2 Inhibitor III |
ERK
,
MAPK
,
MNK
|
|
MK2-IN-3 hydrate (MK-2 Inhibitor III) is an orally active, selective, and ATP-competitive inhibitor of MAPKAP-K2 (MK-2) (IC50 of 0.85 nM) |
|
T14988 |
CMPD1
|
|
MAPK
|
|
CMPD1 is a non-ATP-competitive p38 MAPK-mediated MK2 phosphorylation inhibitor(apparent Ki (Kiapp): 330 nM). |
|
T16501 |
PF-3644022
|
|
p38 MAPK
,
Serine Protease
,
MAPK
|
|
PF-3644022 is an effective, selective, and ATP-competitive MAPKAPK2 (MK2) inhibitor (IC50: 5.2 nM and a Ki of 3 nM). PF-3644022 potently inhibits TNFα production and has an anti-inflammatory effect. PF-3644022 also inhib... |
|
T39321 |
CC-99677
|
CC99677,Gamcemetinib,CC 99677 |
HSP
,
MAPK
|
|
CC-99677 (Gamcemetinib) is a selectively targeted covalent MAPKAPK2 (MK2) inhibitor for autoimmune diseases that translates biochemical potency into cellular potency as demonstrated by potent inhibition of heat shock pro... |
|
T62110 |
MK2-IN-4
|
|
|
|
MK2-IN-4 is a MAPKAPK2 (MK2) inhibitor (IC50: 45 nM). MK2-IN-4 can be used in cancer, inflammation and immunology studies. |
|
T36778 |
MK2-IN-1
|
MK2-IN-1 (MK2 Inhibitor) |
|
|
MK2-IN-1 is a potent and selecitve MAPKAPK2(MK2) inhibitor(IC50=0.11 uM) with a non-ATP competitive binding mode. |
